The FDA has appointed hematologist-oncologist Vinay Prasad, MD, to lead the agency’s Center for Biologics Evaluation and Research, according to a May 6 NBC News report. As the head of CBER ...

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...

Johnson & Johnson has generated evidence that the pace of oncology innovation is overwhelming physicians. A recent survey commissioned by the company found oncologists are struggling to keep up ...

As Dr Rundquist explained, Dana-Farber Cancer Institute’s comprehensive approach to oncology nursing education has significantly improved workforce retention and clinical preparedness.

But this guest star role feels different. A decorated war veteran and night-shift attending physician, Dr. Jack Abbot on Max’s “The Pitt” wasn’t really on Hatosy’s radar. The day of our ...

Dr. Ang is a Senior Consultant, Medical Oncologist and Medical Director of Parkway Cancer Centre in Singapore. He is experienced in managing a wide range of cancers including lung cancer ...

An oncologist warned that repeatedly needing the ... proof of cancer as they could also result from an enlarged prostate. Dr Kubes highlighted: "Lots of men develop an enlarged prostate as they ...

Dr Jiri Kubes, a radiation oncologist at theProton Therapy Center, said: “Getting up to use the toilet in the night is very common and tends to occur more often as we age, so it’s not ...

The Food and Drug Administration on Tuesday named Dr. Vinay Prasad — a hematologist-oncologist who has been accused of spreading misinformation about Covid vaccines and was an outspoken critic ...

The center’s design effort was led by Jeanine Rundquist, DNP, RN, executive director of Dana-Farber’s Center for Clinical and Professional Development and other expert oncology nurses.

(Reuters) - The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized the FDA and was a fierce critic of COVID-19 vaccine and mask mandates ...

and personalised treatment optimisation are reshaping the oncology trial landscape, as Advanced Clinical's Dr Ravi Karra explains. Pharmaphorum’s editor-in-chief Jonah Comstock highlights ASCO ...